| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | Chief Legal Officer | Common Shares | 4,893 | $294,108 | $60.11 | 10 Mar 2026 | Direct |
| Xenon Pharmaceuticals Inc. | Chief Legal Officer | Share Option (Right to Buy) | 80,000 | 09 Jan 2026 | Direct | ||
| Xenon Pharmaceuticals Inc. | Chief Legal Officer | Restricted Share Units | 15,000 | 09 Jan 2026 | Direct | ||
| Xenon Pharmaceuticals Inc. | Chief Legal Officer | Performance Share Units | 0 | 09 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 09 Mar 2026 | 4 | -$156,702 | 4 | Chief Legal Officer | 11 Mar 2026, 19:20 |
| XENE | Xenon Pharmaceuticals Inc. | 09 Jan 2026 | 2 | $0 | 4 | Chief Legal Officer | 09 Jan 2026, 18:52 |
| XENE | Xenon Pharmaceuticals Inc. | 12 Mar 2025 | 2 | $0 | 4 | Chief Legal Officer | 13 Mar 2025, 19:30 |
| XENE | Xenon Pharmaceuticals Inc. | 11 Mar 2024 | 1 | $0 | 4 | Chief Legal Officer | 12 Mar 2024, 18:34 |
| XENE | Xenon Pharmaceuticals Inc. | 10 Mar 2023 | 1 | $0 | 4 | Chief Legal Officer | 14 Mar 2023, 16:44 |
| XENE | Xenon Pharmaceuticals Inc. | 07 Nov 2022 | 1 | $0 | 4 | Chief Legal Officer | 09 Nov 2022, 16:04 |
| XENE | Xenon Pharmaceuticals Inc. | 07 Nov 2022 | 0 | $0 | 3 | Chief Legal Officer | 09 Nov 2022, 15:59 |